Impact of COVID-19 pandemic on central-line–associated bloodstream infections during the early months of 2020, National Healthcare Safety Network
Prachi Patel(Centers for Disease Control and Prevention), Andrea L. Benin(Centers for Disease Control and Prevention), Lucy Fike(Centers for Disease Control and Prevention), Lindsey M. Weiner(Centers for Disease Control and Prevention), David T. Kuhar(Centers for Disease Control and Prevention), Daniel A. Pollock(United States Department of Health and Human Services), Margaret A. Dudeck(Manhattan Institute for Policy Research), Jonathan R. Edwards(Centers for Disease Control and Prevention)
Cited by 81
Related Papers
CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
|American Journal of Infection Control|2008|6.6k
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014
|Infection Control and Hospital Epidemiology|2016|1.3k
National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009
|American Journal of Infection Control|2009|1.3k
Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017
|Infection Control and Hospital Epidemiology|2019|714
National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module
|American Journal of Infection Control|2013|658